Eyecare

The Phoroptor Makes History and More of What You Need to Know for February

Including the ongoing increase in Glaucoma and why some suffers choose to forgo treatment.

Published

2 years ago

February 20, 2022

INVISION Staff Invision February 2022 Issue

Reichert-Phoroptor-100-Years-PR-FINAL-image

The Phoroptor Turns 100!

The tool synonymous with eye exams is turning 100. On Jan. 10, 1922, the US Patent Office granted a registered trademark to the word Phoroptor. In 1915, Henry DeZeng introduced the Model 570 Phoro-Optometer, the foundation of 1922’s No. 584 Phoroptor, the first official Phoroptor refracting instrument. American Optical Company, predecessor of today’s Reichert Technologies, bought DeZeng Standard in 1925. The Additive Effective Power 589 Phoroptor was released in 1934, with Jackson Cross Cylinder lenses and the iconic question, “Better 1 or better 2?” Visit Reichert to learn how they will commemorate this anniversary. reichert.com/phoroptor100

Glaucoma and Red Eyes

Bausch + Lomb and the Glaucoma Research Foundation released findings on the impact hyperemia has on the lives of people with glaucoma. Dissatisfaction with side effects of treatment is among the top reasons for non-adherence, with hyperemia causing some to stop or skip medication. The survey included 101 adults who have glaucoma and experienced hyperemia. It found that few knew about hyperemia when starting treatment; 61% only became aware of it after experiencing it. Nearly half talked to their doctors about changing treatment as a result and 12 out of 101 skipped doses or stopped using Rx eye drops. 66 out of 101 reported feeling more confident when their eyes were not red. glaucoma.org | bausch.com

Glaucoma Up 2% Annually

Total prevalent cases (diagnosed and undiagnosed) of primary open angle glaucoma (POAG) are expected to rise at an annual rate of 2% from 7.3 million in 2020 to 8.84 million in 2030 in the seven major markets (7MM) — US, France, Germany, Italy, Spain, UK, Japan — GlobalData said. The rise is due to an aging population, more comorbid conditions, and delayed access to health facilities. According to the report Glaucoma: Epidemiology Forecast to 2030, more than half of POAG cases remained undiagnosed in the 7MM in 2020. “The increasing number of the aging population with undiagnosed POAG suggests POAG related blindness will continue to rise,” said Bishal Bhandari, PhD at GlobalData. globaldata.com

INVISION Staff

Since launching in 2014, INVISION has won 23 international journalism awards for its publication and website. Contact INVISION's editors at editor@invisionmag.com.

click to Comment(Comment)

Up Next

ECPs Share Their Best-Selling Collections for December 2021

Don't Miss

Inspect the Specs: Martha Stewart and Snoop Dogg’s Spectacular Diamond Spectacles

The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width³ according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion⁴ and seamless transitions from near to far.

For more information, visit here.